期刊名称：BRAIN RESEARCH BULLETIN
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Instructions to Authors
Aims and Scope
Brain Research Bulletin is dedicated to the rapid publication of significant research articles and reviews in all areas of the neurosciences. In addition to reports of original research, the journal will also publish general and speculative reviews, topical debates, methodological developments, theoretical articles, articles on the history of neuroscience, and occasional special issues. The editors are committed to maintaining a high quality of all published reports and to a rapid and fair review process. Manuscripts will be subject to a process of anonymous review (the names of authors and their affiliations will be disclosed to the referees only when the review process is complete). Accelerated publication is the goal for all manuscripts. Articles will be published in English.
Types of manuscripts published
The major part of each issue will be comprised of original research reports. Since the goal is to achieve rapid publication of all reports, there will be no separate section of short or rapid communications. Editorial policy will favour conciseness but longer or multi-experiment papers are equally acceptable where appropriate for proper communication of the results. The journal will also publish high quality reviews of a variety of types, methodological papers where they contribute a scientific advancement, articles on the history of neuroscience, letters to the editor including scientific correspondence commenting on the methods or interpretation in other published papers, and occasional special issues. Authors are encouraged to contact the relevant section editor to discuss opportunities for submission of articles that do not fall into the standard categories
Submission of manuscripts
All manuscripts should be prepared in quadruplicate (including 4 copies of all figures and plates properly collated with the body of the text) and submitted to the relevant section editor:
- Cellular and Molecular Neurobiology
Ian S. Zagon, Department of Neuroscience and Anatomy, Room C3729, M.S. Hershey Medical Center, 500 University Drive, Hershey, PA 17033, USA. tel. (+1) 717 531 8650; fax (+1) 717 531 5184; e-mail isz1@psu.edu
- Cognition and Behaviour
Stephen B. Dunnett, School of Biosciences, Cardiff University, Museum Avenue, Cardiff , CF10 3US, UK.
Tel. (+44) 29 20 875188; fax (+44) 29 20 876749; e-mail Dunnett@cf.ac.uk
- Development and Regeneration
Andrew D. McClellan, Division of Biological Science, 114 Lefevre Hall, University of Missouri, Columbia, MO 65211-6190, USA. tel. (+1) 573 882 1447; fax: (+1) 573 884 5020; e-mail McclellanA@missouri.edu
- Functional and Molecular Neuroanatomy, and Experimental Neuropathology
Marina Bentivoglio, Department of Morphological and Biomedical Sciences, Section of Anatomy and Histology, Medical Faculty, University of Verona, Strada Le Grazie 8, 37134 Verona, Italy. tel. (+39) 045 8027 158; fax (+39) 045 8027 163; e-mail marina@anatomy.univr.it
- Neuropharmacology and Neuroendocrinology
E. Sylvester Vizi, Institute of Experimental Medicine, Hungarian Academy of Sciences, Szigony u. 43, H-1083 Budapest, Hungary. tel. (+36) 1 210 0810; fax (+36) 1 210 0813; e-mail esvizi@koki.hu
- Neurophysiology and Computational Neuroscience
Adonis Moschovakis, Institute of Applied and Computational Mathematics, F.O.R.T.H., P.O. Box 1527, Heraklion 71110, Crete, Greece. tel. (+30) 81 394 509; fax (+30) 81 391 801; e-mail moschov@med.uoc.gr
- Normal and Pathological Human Brain Function
Pietro Pietrini, Institute of Medical Biochemistry, Medical School, University of Pisa, Via Roma 55, I-56126 Pisa, Italy. Tel (+39) 50 561 912; fax (+39) 50 550 241; e-mail: pietro.piettrini@bm.med.unipi.it
In cases of uncertainty, manuscripts may be submitted directly to the Editor-in-Chief, Stephen B. Dunnett, at the above address.
Preparation of manuscripts
- Manuscripts should be double-spaced throughout with wide margins on good quality paper. Text should not be justified, but flush left. Words should not be hyphenated to fit on a line. Pages should be numbered sequentially. Articles must be written in English, with either British or American spelling used consistently throughout.
- The first page should contain: title of paper (in upper and lower case, to ensure proper transcription when indexing, e.g., "NADPH-diaphorase" or "basal nucleus of Meynert"); author(s); laboratory or institution of origin with city, state, postal/zip code, and country; complete name and address for correspondence with telephone and fax numbers, and e-mail address if available; running head not to exceed 40 characters including spaces. This first page will not be sent to referees.
- The second page should contain only the title and running head. This page will serve as the cover when the manuscript is sent to referees.
- The third page should contain the abstract and keywords. The abstract should be suitable for abstracting journals and should not exceed 200 words. The use of abbreviations should be avoided in the abstract. A list of 4-6 keywords suitable for indexing terms and not included in the title should be typed below the abstract.
- Research papers should be organised in a standard form with separate Introduction, Materials and Methods, Results and Discussion sections. Review articles should be divided into sections and subsections as appropriate. Sections and subsections should not be numbered
- Acknowledgements, references, figure legends and each table should be typed on separate sheets.
- Authors are invited to submit the names, addresses, telephone and fax numbers and e-mail (if available) of up to 4 potential reviewers.
- The final version of the paper should be accompanied by a version on computer disk.
Anonymous Review
- In order to promote fairness of the review process, it is the editors' intention to provide anonymous review of all manuscripts. In order to achieve this, the first page and the acknowledgements page will be removed from the manuscripts sent to referees.
- If authors wish to maintain anonymity, manuscripts should be written accordingly; i.e. their names should not appear explicitly in the body of the text (e.g., "as we have reported previously [ref]"), appear as page headers, nor be written on the back of the figures.
- In order for the editors to select the most appropriate referees, authors are invited to submit the names of potential reviewers as explained above.
Authorship
All authors are expected to have contributed significantly to the work. In cases of doubt, this should be taken to imply contribution to at least two of the following: experimental design, data collection, data analysis, and writing of the report.
Dimensions and measurements
All dimensions and measurements must be specified in the metric system. Standard nomenclature, abbreviations and symbols will be based on the Vancouver convention. (Refer to the Appendix of Brain Research Bulletin, volume 36, number 1, 1995 and/or to the CBE Style Manual.)
Drugs and special reagents
The source of all compounds should be identified. The chemical names of any drug should precede the trade name, popular name or abbreviation the first time it occurs. Publication in the journal implies a willingness by the authors to make special materials, including antibodies, amino acids and cell lines, freely available to other scientists for legitimate academic purposes wherever possible.
Design and statistical analysis
Particular attention needs to be paid to the selection of appropriate analyses of data.
- Be consistent in the use of either parametric or non-parametric tests.
- Pay attention to the logical fallacy of concluding in favour of the null hypothesis.
- Pay attention to the proper identification and analysis of repeated measures in designed experiments.
- Where an experiment involves a factorial design, undertake the proper multifactorial analysis - a series of multiple single factor analyses or independent pairwise comparisons are not acceptable.
- Similarly, use the proper post hoc tests for multiple comparisons to evaluate the locus of significant main effects or interactions - again, multiple independent uncorrected pairwise comparisons are not acceptable.
- The results of statistical tests should be incorporated in the body of the text, typically in the Results section, rather than in figure legends. Do not include full analysis of variance summary tables, but only summary statistics with test value, degrees of freedom and level of significance. The appropriate form for reporting variance ratios in analyses of variance is, for example, F(2,48)=3.05, p<0.01, with a similar style as appropriate for other statistical tests. Statistical measures of variation in the text, illustrations and tables, (e.g. SD, SEM) should be identified.
Formulae and equations
All subscripts, superscripts, Greek letters and unusual characters must be clearly identified.
Abbreviations
Abbreviations should be defined on first use in the text, unless in very common and general usage (e.g. subcutaneous s.c.). A list of standard abbreviations is available upon request. Where many abbreviations occur, a separate list related to the whole article should be provided on a separate page. Such a list should in any case be provided when multiple anatomical abbreviations are repeated in several figure legends.
Italicisation
Foreign, in particular Latin and Greek, terms should be italicised (e.g. in vivo, in vitro, in situ, per se, de novo, post mortem). Genes (e.g. c-fos, c-jun, fos-B, myc) and species (e.g. Macaca mulatta, Rana catesbeiana) should also be italicised as illustrated, whereas the protein products of genes (e.g. Fos) should have a leading capital but are not italicised.
References
- Footnotes are not a part of normal scientific reports. Relevant material should be included in the text or in references. Reference citations should only be to published material or manuscripts that are accepted for publication and 'in press'. Other references to manuscripts which are still in preparation or submitted but not yet accepted should be referred to in the text as 'unpublished data' or 'personal communications'.
- All references cited in the text should be listed on a separate page(s) at the end of the article, arranged in alphabetical order according to first author, and numbered consecutively. Literature cited should be prepared according to the numbered/alphabetised style of the Council of Biology Editors (CBE). Citation of literature references in the text should be given at the appropriate places by numbers in square brackets. All items in the reference list should be cited in the text and conversely all items cited in the text must be included in the reference list.
- Literature references must be complete, including the names and initials of all authors, title of the paper, abbreviated title of the journal, volume, first and last pages of the article, and year (example 1 below). In cases of doubt, abbreviations of journal titles should comply with the List of Serial Title Word Abbreviations, CIEPS/ISDS, Paris, 1985, ISBN 2-904938-02-8. References to books should follow the form: names and initials of all authors, title of the book, city, publisher and year (example 2 below). References to chapters in multi-author books should follow the form: names and initials of all authors, title of the chapter, names and initials of all editors, title of the book, city, publisher, year, and first and last pages of the article (example 3 below).
1. Gerren, R.A.; Johnson, T.C. Changes in sciatic nerve and spinal cord function induced by a CNS viral infection. Brain Res. Bull. 34: 79-84; 1994.
2. Cooper, J.R.; Bloom, F.E.; Roth, R.H. The biochemical basis of neuropharmacology, 5th edition. New York & Oxford: Oxford University Press; 1986.
3. Wang, J.; Bankiewicz, K.S.; Plunkett, R.J.; Sheng, J.; Jacobowitz, D.M. Transplantation of microglia reduces experimental parkinsonism in rats. In: Lindvall, O.; Björklund, A.; Widner, H., eds. Intracerebral transplantation in movement disorders: Experimental basis and clinical experiences. Restorative neurology, vol. 4. Amsterdam: Elsevier; 1991: 3313-324.
- This journal should be abbreviated as Brain Res. Bull.
Computer disks
Authors are encouraged to submit a 3.5" HD/DD computer disk to the editorial office; 5.25" HD/DD disks are acceptable if 3.5" disks are unavailable. Please observe the following criteria:
- Send only hard copy when first submitting your paper.
- When your paper has been refereed, revised if necessary, and accepted, send a disk containing the final version with the final hard copy. Make sure that the disk and the hard copy match exactly (otherwise the diskette version will prevail).
- Special symbols that are not reproduced in the computer copy must be indicated explicitly on the hard copy.
- Specify what software was used, including which release, e.g. WordPerfect 6.0a.
- Specify what computer was used (IBM compatible PC, Apple Macintosh, etc.).
- The article file should include all textual material (text, references, tables, figure captions, etc.) and separate illustration files, if available.
- The file should follow the general instructions on style/arrangement and, in particular, the reference style of this journal as given in these Instructions to Authors.
- The file should be single-spaced and should use the wrap-around end-of-line feature, i.e. returns at the end of paragraphs only. Place two returns after every element such as title, headings, paragraphs, figure and table call-outs.
- Keep a back-up disk for reference and safety.
-
Illustrations
- Prepare illustrations for use in a single column width (84 mm) whenever possible, or otherwise in double column width (174 mm).
- All illustrations should be referred to in the text as figures, and numbered sequentially using Arabic numerals (Fig. 1, Fig. 2, etc.). There should be one unique number for each separate plate or figure, and each will be accompanied by its own figure legend. Panels within figures should be labelled by capital letters (A, B, C, and so on) and referred to in the text by figure number and the same letters (e.g., Fig. 1A, Figs. 2B,C, etc.). Do not refer to panels in figures by their position (e.g. "top right").
- All drawings for reduction to a given size should be drawn and lettered to the same scale. Lettering should be proportional to the size of the illustrations, such that the smallest letters will be legible when reduced.
- When possible, all lettering should be within the framework of the illustration. Likewise, the key to symbols should be within the framework of charts and graphs, rather than in the figure legend. When preparing graphs or histograms, please include an indication of the variability of the data as well as the mean or median values (e.g. standard error or standard deviation bars for parametric data; scatter plots or interquartile ranges for non-parametric data). Employ a judicious range of shadings and fills to ensure that columns in histograms are easily distinguished between different groups and treatments. Do not use 3-dimensional representations of bars in histograms or plots in graphs, other than when explicitly required to represent three dimensions in the data.
- Photomicrographs should be grouped into plates, mounted on white paper or thin card, and prepared for reproduction at 100% size. Like all other figures, plates should be prepared within a rectangular frame to fit within a single or double column width of 84 mm and 174 mm, respectively, and a maximum page height of 226 mm. The panels of a plate should be accurately aligned, so that the amount of white space between panels is of equal width (0.5 - 1.0 mm). Irregular figures (e.g. electrophysiology traces) should be organised so as to minimise white space between areas sensibly. Each plate should include scale magnification bars within each panel of the photomicrographs, as appropriate; do not use magnification factors in the figure legends.
- Illustrations involving brain outlines or camera lucida drawings should contain major landmarks for reference to location.
- High quality prints/copies of each photomicrograph, plate or other halftone figure are required to accompany each manuscript (an original plus three copies in total), and must be mounted on pages the same size as the manuscript. Photocopies are not acceptable for review purposes.
- Colour figures and plates can be included, but the expense must be borne by the authors. The cost of colour reproduction in the journal is $300 for the first page and $200 for each subsequent page.
- The top copy of original plates can be returned, if requested at the time of submission, in cases of rejection only.
Tables
- Each table should have a brief but descriptive heading.
- The major divisions of a table should be indicated by horizontal rules. Short or abbreviated column heads should be used. Vertical rules should be avoided.
- Explanatory matter should be included in footnotes to the table. Footnotes should be indicated in the body of the table in order of their appearance either with the following symbols: * † ‡ ¡ì ¶ # **, etc., or with superscript numbers: 1 2 3 etc.
- Tables must not duplicate material in the text or in illustrations.
Ethical consideration
Submission of a manuscript implies that the authors have given full attention throughout to the ethical aspects of their research.
- When human subjects are used, manuscripts must be accompanied by a statement that the experiments were undertaken with the understanding and written consent of each subject, with the approval of the appropriate local ethics committee, and in compliance with national legislation and the Code of Ethics of the World Medical Association (Declaration of Helsinki), which has been reproduced in the British Medical Journal (18 July 1964).
- When experimental animals are used, the materials and methods section must clearly indicate that adequate measures were taken to minimise pain or discomfort, and that the experiments were conducted in accordance with national legislation, and with the European Communities Council Directive of 24 November 1986 (86/609/EEC) or the National Institutes of Health Guide regarding the care and use of animals for experimental procedures. Full details of any anaesthetic or analgesic dose and treatment must be given.
Proofs
In order to maintain rapid publication, proofs should be returned within 48 hours of receipt by fax or courier mail. Corrections to the proofs should be restricted to printer's errors only; other alterations will be charged to the author.
Reprints
Each corresponding author will receive with the page proofs a reprint order form which must be completed and returned with the proofs. Corresponding authors will receive 50 free reprints of their article.
Copyright
Publications are made subject to copyright for the protection of the authors and the publisher. A Transfer of Copyright Agreement will be sent to the corresponding author at the time of either preliminary or final acceptance. The form must be completed and returned to the publisher before the article can be published.
The latest version of these instructions to authors is maintained on our web site at http://www.brb.cf.ac.uk/brb/instruct.htm
For further information contact the Editor-in-Chief, Stephen Dunnett, or the Editorial Assistant, Kim Davis
Return to: Brain Research Bulletin home page.
Return to: Steve Dunnett's home page.
Editorial Board
|
Editor-in-Chief
|
|
|
Stephen B. Dunnett, School of Biosciences, Cardiff University, Biomedical Science Building, Museum Avenue, PO Box 911, Cardiff, Wales CF1 3US
|
|
Cellular and Molecular Neurobiology:
|
|
|
Ian S. Zagon, M.S. Hershey Medical Center, Department of Neuroscience and Anatomy, Room C3729, 500 University Drive, Hershey, PA 17033, USA
|
|
Development and Regeneration:
|
|
|
Andrew D. McClellan, University of Missouri, Division of Biological Science, 105 Lefevre Hall, Columbia, MO 65211-6190, USA
|
|
Cognition and Behavior:
|
|
|
Stephen B. Dunnett, School of Biosciences, Cardiff University, Biomedical Science Building, Museum Avenue, PO Box 911, Cardiff, Wales CF1 3US
|
|
Functional and Molecular Neuroanatomy, and Experimental Neuropathology:
|
|
|
Marina Bentivoglio, Department of Morphological and Biomedical Sciences, Section of Anatomy & Histology, Faculty of Medicine, University of Verona, Strada Le Grazie 8, 37134, Verona, Italy
|
|
Neuropharmacology and Neuroendocrinology:
|
|
|
E. Sylvester Vizi, Institute of Experimental Medicine, Hungarian Academy of Sciences, H-1450 Budapest, P.O. Box 67, Hungary
|
|
Neurophysiology and Computational Neuroscience:
|
|
|
Adonis Moschovakis, Institute of Applied and Computational Mathematics, F.O.R.T.H., P.O. Box 1527, Heraklion 71110, Crete, Greece
|
|
Normal and Pathological Human Brain Function:
|
|
|
Pietro Pietrini, Institute of Medical Biochemistry, Medical School, University of Pisa, Via Roma 55, I-56126, Pisa, Italy
|
|
Editorial Board:
|
|
|
E. Abercrombie, Rutgers University, Newark, NJ, USA
|
|
|
J. Aggleton, University of Wales, Cardiff, Wales
|
|
|
M. Bickford, University of Louisville, Louisville, KY, USA
|
|
|
A. Björklund, University of Lund, Lund, Sweden
|
|
|
T. Carlstedt, Royal National Orthapaedic Hospital, Middlesex, England
|
|
|
I. Curthoys, University of Sydney, Australia
|
|
|
R. Drucker-Colin, Universidad Nacional Autonoma De Mexico, Mexico City, Mexico
|
|
|
A.P. Georgopoulos, University of Minnesota Medical School, Minneapolis, MN, USA
|
|
|
B. Ghetti, Indiana University School of Medicine, Indianapolis, IN, USA
|
|
|
S.R. Goodman, University of South Alabama, Mobile, AL, USA
|
|
|
A. Grantyn, CNRS Laboratoire de Physiologie Neurosensorielle, Paris, France
|
|
|
H.J. Groenewegen, Vrije Universiteit, Amsterdam, The Netherlands
|
|
|
R.E. Harlan, Tulane Univesity, New Orleans, LA, USA
|
|
|
A.R. Harvey, The University of Western Australia, Perth, Australia
|
|
|
M.H. Hastings, University of Cambridge, Cambridge, UK
|
|
|
M.A. Herkenham, National Institute of Mental Health, Bethesda, MD, USA
|
|
|
T. Kaneko, Kyoto University, Kyoto, Japan
|
|
|
O. Kiehn, Dept. of Neuroscience, Stockholm, Sweden
|
G.K. Kostopoulos, University of Patras Medical School, Patras, Greece
|
|
K.S. Kristensson, Karolinska Institute, Stockholm, Sweden
|
|
G. Kunos, National Institute for Alcohol Abuse & Alcoholism, Bethesda, MD, USA
|
|
J.Y. Kuwada, University of Michigan, Ann Arbor, MI, USA
|
|
L. L¨¦n¨¢rd, P¨¦cs University Medical School, P¨¦cs, Hungary
|
|
A. Lansner, Dept of Numerical Analysis and Computer Science, Stockholm, Sweden
|
|
A.A. Lev-Tov, Hebrew University Medical School, Jerusalem, Israel
|
|
G.B. Makara, Hungarian Academy of Sciences, Budapest, Hungary
|
|
P.J. McLaughlin, Pennsylvania State University, Hershey, PA, USA
|
|
M. Molinari, Laboratory of Experimental Neurorehabilitation, Rome, Italy
|
|
R.D. Myers, East Carolina University, Greenville, NC, USA
|
|
M.J. O'Donovan, NINDS/NIH, Bethesda, MD, USA
|
|
M.L. Oster-Granite, National Institute of Child Health & Human Development, Bethesda, MD, USA
|
|
C.R. Plata-Salam¨¢n, The R.W. Johnson Pharmaceutical Research Institute, Spring House, PA, USA
|
|
P.R. Sanberg, University of South Florida, Tampa, FL, USA
|
|
I. Segev, Hebrew University, Jerusalem, Israel
|
|
H. Sershen, Nathan S. Kline Insitute, Orangeburg, NY, USA
|
|
T. Slotkin, Duke University Medical Center, Durham, NC, USA
|
|
J.D. Steeves, University of British Columbia, Vancouver, Canada
|
|
L. Swanson, University of Southern California, Los Angeles, CA, USA
|
|
R. Weinberg, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
|
|
I.Q. Whishaw, University of Lethbridge, Canada
|
|
P. Winn, University of St. Andrews, Fife, UK
|
|
|
